• / Free eNewsletters & Magazine
  • / My Account


Endocan Corp ENDO

Last Price$0.02Day Change (%)3.40%
Open Price$0.02Day Change ($)0.00
Day Range0.02–0.0252-Week Range0.00–0.04

As of Thu 10/27/2016 4:58:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Investing
  1. The Market: Exaggerated Woes

    Endo Pharmaceuticals ENDP announced July 11 that it no longer expects to file a new drug application for its ketoprofen pain-relief patch by the first half of 2008 because of lackluster Phase III trial results. The drug candidate failed to show statistically significant results for pain relief in ...

  2. Health Care: 3 Picks in a More Expensive Sector

    Despite the sector looking slightly overvalued overall, we still see stocks that offer attractive valuations across the different industries.

  3. Actavis' Wide-Moat Transformation Offers Shareholder Rewards

    Product durability, diversification, and cost synergies support strong earnings growth for this undervalued wide-moat firm.

  4. Credit Market Outlook: Tight Spreads Will Keep a Lid on Returns

    As credit spreads have tightened on a nearly continuous trend over the past year, they are becoming richly valued relative to their historical average.

  5. Our Outlook for the Credit Markets

    The corporate bond market will probably struggle to return much above break-even in 2014.

  6. Covidien's Mallinckrodt Spin-Off Faces Challenging Environment

    Mallinckrodt's lack of scale and weak branded business keep it from earning a moat.

  7. A Bounty of Ideas from Berkshire's Portfolio

    A look at Berkshire's 5-star holdings.

Upcoming Events

©2014 Morningstar Advisor. All right reserved.